• Explore /
  • Poster
  • / Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database.

Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database.

Abstract Poster

Authors

null

Daniel Kejzman

Genitourinary Oncology Service, Division of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel

Daniel Kejzman , Maya Gottfried , Natalie Maimon , Hans J. Hammers , Mario A. Eisenberger , Michael Anthony Carducci , Victoria J. Sinibaldi , Victoria Neiman , Eli Rosenbaum , David Sarid , Eliahu Gez , Avivit Peer , Avishay Sella , Wilmosh Mermershtain , Keren Rouvinov , Raanan Berger , Jae-Lyun Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 486)

DOI

10.1200/jco.2014.32.4_suppl.486

Abstract #

486

Poster Bd #

G1

Abstract Disclosures

Similar Posters

First Author: Pia Paffenholz

First Author: Chung-Han Lee

Poster

2018 Genitourinary Cancers Symposium

Activity of third line (3L) therapy in patients with metastatic non-clear-cell renal cell carcinoma (mnccRCC).

Activity of third line (3L) therapy in patients with metastatic non-clear-cell renal cell carcinoma (mnccRCC).

First Author: Annalisa Guida

First Author: Daniel Keizman